Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I)-Reference-Cited by-同舟云学术

Comparison of prasugrel and clopidogrel in patients with non-cardioembolic ischaemic stroke: a phase 3, randomised, non-inferiority trial (PRASTRO-I)

Published:2019-03 Issue:3 Volume:18 Page:238-247
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Ogawa Akira,Toyoda Kazunori,Kitagawa Kazuo,Kitazono Takanari,Nagao Takehiko,Yamagami Hiroshi,Uchiyama Shinichiro,Tanahashi Norio,Matsumoto Masayasu,Minematsu Kazuo,Nagata Izumi,Nishikawa Masakatsu,Nanto Shinsuke,Abe Kenji,Ikeda Yasuo

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference30 articles.

1. Japanese guidelines for the management of stroke, updated version 2017,2017

2. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association;Kernan;Stroke,2014

3. Risk score for predicting recurrence in patients with ischemic stroke: the Fukuoka stroke risk score for Japanese;Kamouchi;Cerebrovasc Dis,2012

4. Effectiveness of antiplatelet therapy in atherosclerotic disease: comparing the ASA low-response prevalence in CVD, CAD and PAD;Meves;J Thromb Thrombolysis,2014

5. Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke;Liu;Acta Pharmacol Sin,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Les antiplaquettaires dans l’ischémie cérébrale aiguë : limites et perspectives;Bulletin de l'Académie Nationale de Médecine;2024-08

2. The pharmacology of antiplatelet agents for primary, secondary, and tertiary prevention of ischemic stroke;Expert Opinion on Pharmacotherapy;2024-07-02

3. Efficacy of prasugrel versus clopidogrel for early neurological deterioration in branch atheromatous disease: An exploratory study;Neurology and Clinical Neuroscience;2024-05-09

4. An overview of the utility of prasugrel hydrochloride as a treatment option for ischemic stroke;Expert Review of Neurotherapeutics;2023-12-30

5. Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke;Journal of the American College of Cardiology;2023-10